Skip to content

The effect of vitamin D on the improvement of abdominal pain

The effect of different levels of vitamin D on the supply of children with inflammatory bowel disease

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201011075123N1
Enrollment
60
Registered
2017-07-15
Start date
2016-08-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Disease. Noninfective inflammatory bowel disease

Interventions

Intervention 1: In the first intervention group, daily dose of 800 units of vitamin D is administered for 6 weeks. because the availability of 50,000 single pearls on the market, aggregate daily dose
Treatment - Drugs
In the first intervention group, daily dose of 800 units of vitamin D is administered for 6 weeks. because the availability of 50,000 single pearls on the market, aggregate daily doses may be given a
In the second intervention group, daily dose of 3000 units of vitamin D is administered for 6 weeks. because the availability of 50,000 single pearls on the market, aggregate daily doses may be given

Sponsors

Vice chancellor for research, Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 24 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Inflammatory bowel disease; patient and patient's parents satisfaction Exclusion criteria: Failure to perform tests in all project stages; taking the supplementation incorrectly; patient dissatisfaction for continuation of the project

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Clinical Symptoms. Timepoint: Befor the trial. Method of measurement: Questionnaire.;Severity of disease. Timepoint: Befor the trial. Method of measurement: Questionnaire.

Secondary

MeasureTime frame
VIT D. Timepoint: After the trial. Method of measurement: HPLC.;Ca & P. Timepoint: After the trial. Method of measurement: Enzymatic.;Level of serumic Albmin. Timepoint: After the trial. Method of measurement: Enzymatic.;Level of serumic Feritin. Timepoint: After the trial. Method of measurement: chemoluminescence.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMajid Khademian

Mashhad University of Medical Sciences

khademianm941@mums.ac.ir+98 51 3801 2753

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026